Reports of Patent, Design, and Trade Mark Cases, Issues 1-5; Issues 8-13Published at the Patent Office Sales Branch, 2003 - Industrial property |
From inside the book
Results 1-3 of 66
Page 413
... defendants eight weeks after the main substantive hearing of this application for revocation of the defendants ' patent . Taking account of those submissions would , according to the defendants , involve ordering disclosure , allowing ...
... defendants eight weeks after the main substantive hearing of this application for revocation of the defendants ' patent . Taking account of those submissions would , according to the defendants , involve ordering disclosure , allowing ...
Page 429
... defendants ' witnesses , Mr Holt and Mr Ridgeway , were sitting right behind Mr Leaman . Without a shred of evidence from Mr Fernando ( e.g. culled from the cross examination ) that Mr Gil's legal representatives - whether in the United ...
... defendants ' witnesses , Mr Holt and Mr Ridgeway , were sitting right behind Mr Leaman . Without a shred of evidence from Mr Fernando ( e.g. culled from the cross examination ) that Mr Gil's legal representatives - whether in the United ...
Page 431
... defendants ' hope that such cross - examination would discredit Mr Gil as a witness to such an extent that I would end up throwing out most , if not all , his evidence , but that , of course , would achieve nothing if they were still ...
... defendants ' hope that such cross - examination would discredit Mr Gil as a witness to such an extent that I would end up throwing out most , if not all , his evidence , but that , of course , would achieve nothing if they were still ...
Other editions - View all
Common terms and phrases
ALBERTA FERRETTI amendment Amgen amino acid Appointed Person Arsenal FC Arsenal Football Club burner cell claim 19 claimant colour common general knowledge contact lens CooperVision Court of Appeal cross-examination Davies decision defendants Directive distinctive character DNA sequence dots earlier trade mark effect erythropoietin European Patent evidence filed gene hearing officer High Court Inc v Transkaryotic infringement Integer inventive step iris section issue judge judgment Kirin-Amgen Inc lenses likelihood of confusion Ltd's Trade Mark Marks Act 1994 Meneghetti non-use opponent paragraph numbers paras Patent Office Philips Electronics NV Plc v Reed prior art priority date protein question Quickfit reason Reed Business Information referred registered trade mark registrar relation relevant Remington Consumer Products revocation shape Silverleaf specification submissions Sweet & Maxwell Synthon third party TORRES TRADE MARK 2003 Trade Mark Application trade mark proprietor Trade Marks Act Transkaryotic Therapies Inc uEPO United Kingdom word